The stock market is at all-time highs but biotechnology stocks like Amgen, Inc. (NASDAQ:AMGN) are near their 52 week lows. What gives? There are multiple reasons why the biotechnology stocks have under performed but based on my analysis, that is starting to change. In fact, they are going to play catch-up very quickly! Below are the 3 reasons why every investor should by Amgen, Inc.1. As a majority of stocks are at all-time highs, investors are looking for value. Valuations on financial stocks and many other sectors are in bubble territory. The ONLY sector that is near its 52 week lows is the biotechnology sector. Capital rotation is likely to occur as investors realize there is value here. Amgen, Inc. is one of the leaders that is most secure/safe. It will see a lot of capital flow.2. Over the last two weeks, Amgen, Inc. has seen a gentle slow grind lower known as bullish consolidation. This tells investors that big money is accumulating heavily. In addition, just yesterday price filled a gap fill to the downside. It is major support and a trigger for a move up. Today, Amgen, Inc. is already popping over $3. There is huge upside based on the stock chart, with a target to $160.00.3. The fear of price caps on drugs is way overblown. First it was Hillary Clinton that biotech investors were scared of, now it is Donald Trump. We know Donald Trump is extremely pro business. He is not going to kill the biotechnology sector with massive price caps. He just won't. In this case, the bark is worse than the bite.View my trades and Verified performance now right here. Simply join Verified Investing for free and anytime I buy a stock/ETF, you will get an email. You can then opt-into the trade getting my exact entry price, target and stop. Those who take my trades, only reward me (a Verified Trader) with a few Dollars IF they get big winning trade information.